Live Cell Imaging Market: Growth, Size, Share, and Trends

Report Code BT 3390
Published in May, 2023, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Live Cell Imaging Market by Product (Instruments, Consumables, Software, Services), Application (Cell Biology, Stem Cells, Drug Discovery), Technology (Time-lapse Microscopy, FRET, FRAP, HCS), End User (Pharma, Biotech, CROs) - Global Forecast to 2028

Overview

The global live cell imaging market is projected to reach USD 4.3 billion by 2028 from USD 2.7 billion in 2023, at a CAGR of 10.2% during the forecast period of 2023 to 2028. The growth of this market is majorly driven by growing adoption of high-content screening techniques in drug discovery, rising incidence of cancer, and growing availability of funds for research. On the other hand, the high cost of high-content screening systems is restraining the growth of this market.

Attractive Opportunities in the Live Cell Imaging Market

Asia Pacific

The growth of the Asia Pacific live cell imaging market is primarily due to the increasing investment in healthcare infrastructure and research & development (R&D) activities along with rising prevalence of chronic diseases in the region

Growth in this market is primarily driven by the growing adoption of high-content screening techniques in drug discovery, rising incidence of cancer & growing availability of funds for research

Increasing adoption of live cell imaging technologies in emerging markets are likely to offer potential growth opportunities in the live cell imaging market.

The high cost of high-content screening systems is restraining the market growth.

The Asia Pacific market is estimated to grow at the highest CAGR of 10.7% during the forecast period.

Global Live Cell Imaging Market Dynamics

DRIVER: Growing availability of funds for research

The growing availability of funds for research will drive R&D in the pharmaceutical and biotechnology industries. The governments and various treatment centers of several countries are also promoting and supporting cell-based research. A large portion of government funding is provided to academic research societies (such as Maryland Stem Cell Research Commission, International Human Frontier Science Program Organization (HFSPO), National Institutes of Health (NIH), etc.) to promote cell-based research to advance the diagnostic and therapeutic applications of various types of cells in managing chronic and infectious diseases. Moreover, the growing government funding in regenerative medicine research is expected to drive the demand for advanced live cell imaging technologies, including high-resolution microscopy, image analysis software, and data management tools.

RESTRAINT: High cost of high-content screening systems

The high cost of high-content screening (HCS) systems is one of the major factors restraining the growth of the live cell imaging market. HCS systems are specialized instruments that are designed to automate the process of acquiring and analyzing large amounts of data from live cells. These systems are typically expensive, and the cost can vary depending on the complexity and capabilities of the system.

The high cost of HCS systems can be a barrier for smaller research labs and institutions that may not have the budget to invest in these systems. Additionally, the cost of maintenance, consumables, and software can also add up over time, making it challenging for researchers to sustain the use of HCS systems in their research.

 

OPPORTUNITY: Increasing adoption of live cell imaging technologies in emerging markets

Emerging markets like China, India, and Brazil have experienced rapid expansion in the life science and biotechnology sectors in recent years. Live cell imaging can be used in a variety of fields, including cancer, regenerative medicine, and drug development. These regions have a significant pool of talented researchers, physicians, and scientists who are actively pursuing research in these fields. Such developments in the pharmaceutical and biotechnology industries in these emerging countries are expected to create significant growth opportunities for players operating in the live cell imaging market.

CHALLENGE: Image analysis and data management

Live cell imaging generates large volumes of data over time, presenting challenges in data storage, management, and analysis. Efficient data handling and storage solutions are required to manage the data generated from multiple imaging sessions. Additionally, advanced image analysis algorithms and software are necessary to extract meaningful information from acquired images and enable quantitative analysis of cellular processes. Live cell imaging often involves using multiple software tools and platforms for image acquisition, analysis, and data management. Integrating these tools into a cohesive workflow can be challenging due to compatibility issues, data transfer, and standardization of file formats. Researchers need to ensure seamless data flow between different software packages, facilitate interoperability, and establish standardized protocols to streamline the analysis process.

Global Live Cell Imaging Market Ecosystem Analysis

 

The instruments segment dominated live cell imaging market by product & service:

The instruments segment held the largest share of the global live cell imaging market in 2022. Live cell imaging instruments provide critical insights into the fundamental nature of cellular and tissue function. Several end users opt for automated instruments over manually operated instruments as they are more efficient and provide accurate results. The instruments used in live cell imaging are significantly more expensive than the consumables and software used in these procedures. Additional factors such as the launch of new and advanced instruments, the increasing incidence of diseases, and rising government initiatives and awareness programs to promote cell-based research are the other major factors driving the demand for live cell imaging instruments. The increasing demand for live cells for analysis in the biotech and biopharmaceutical industries is another major factor supporting the adoption of these instruments.

Asia Pacific is estimated to register the highest CAGR during the forecast period.

The live cell imaging market in the Asia Pacific region has experienced significant growth over the past few years. This growth can be attributed to several factors such as increasing investment in healthcare infrastructure and research & development (R&D) activities. Governments and private entities are allocating substantial funds and launching various research programs to enhance healthcare facilities and promote scientific advancements, including live cell imaging technologies. These investments are driving the adoption of live cell imaging techniques across various applications and research fields. Furthermore, in countries such as China and Japan, factors such as rising prominence of regenerative medicine research, low manufacturing costs and the huge demand for medicines is expected to drive market growth, thereby increasing the demand for live cell imaging technologies for studying the cellular dynamics in details.

HIGHEST CAGR MARKET IN 2022
CHINA FASTEST GROWING MARKET IN THE REGION

Recent Developments of Live Cell Imaging Market

  • In February 2023, Nikon Corporation launched the Nikon Spatial Array Confocal (NSPARC) detector for AX systems. This detector enables high-resolution imaging of live tissue with minimal phototoxicity.
  • In January 2022, CytoSMART Technologies launched Omni Pro 12, adding to the Omni live cell imaging product portfolio.

Key Market Players

KEY PLAYERS IN THE LIVE CELL IMAGING MARKET INCLUDE

  • Danaher (US)
  • ZEISS Group (Germany)
  • Nikon Corporation (Japan)
  • Olympus Corporation (Japan)
  • PerkinElmer Inc. (US)
  • Sartorius AG (Germany)
  • Agilent Technologies, Inc. (US)
  • Thermo Fisher Scientific, Inc. (US)
  • Etaluma, Inc. (US)
  • CytoSMART Technologies (Netherlands)
  • NanoEnTek Inc. (South Korea)
  • GE Healthcare (US)
  • Bruker Corporation (US)
  • Becton, Dickinson and Company (BD) (US)
  • Merck KGaA (Germany)
  • Bio-Rad Laboratories, Inc. (US)
  • Blue-Ray Biotech Corp. (Taiwan)
  • CYTENA GmbH (Germany)
  • Nanolive SA (Switzerland)
  • Abberior (Germany)
  • Phase Holographic Imaging (PHI) AB (Sweden)
  • Cytoskeleton, Inc. (US)
  • Corning Incorporated (US)
  • KEYENCE Corporation (Japan)
  • Aligned Genetics, Inc. (South Korea)

Want to explore hidden markets that can drive new revenue in Live Cell Imaging Market?

Scope of the Report

Report Metric Details
Market size available for years 2021–2028
Base Year Considered 2022
Forecast period 2023-2028
Forecast units Value (USD)
Segments covered Product & Service, Application, Technology, and End User
Geographies covered North America, Europe, Asia Pacific, Latin America (LATAM) and Middle East and Africa (MEA)

Key Questions Addressed by the Report

Who are the key players in the live cell imaging market?
Key players in the live cell imaging market include Danaher (US), ZEISS Group (Germany), Nikon Corporation (Japan), Olympus Corporation (Japan), PerkinElmer Inc. (US), Sartorius AG (Germany), Agilent Technologies, Inc. (US), Thermo Fisher Scientific, Inc. (US), Etaluma, Inc. (US), CytoSMART Technologies (Netherlands), NanoEnTek Inc. (South Korea), GE Healthcare (US), Bruker Corporation (US), Becton, Dickinson and Company (BD) (US), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (US), Blue-Ray Biotech Corp. (Taiwan), CYTENA GmbH (Germany), Nanolive SA (Switzerland), Abberior (Germany), Phase Holographic Imaging (PHI) AB (Sweden), Cytoskeleton, Inc. (US), Corning Incorporated (US), KEYENCE Corporation (Japan), and Aligned Genetics, Inc. (South Korea).
Which product and service segment dominates the live cell imaging market?
The instruments segment held the largest share of the global live cell imaging market by product & service segment in 2022. This is primarily attributed to the high cost of live cell imaging instruments compared to the consumables and software used in these procedures, due to which the revenue generated from instruments for live cell imaging remains high.
Which application segment of the live cell imaging market is expected to witness the highest growth?
The cell biology segment held the largest market share by application in 2022. The need for a deeper understanding of cellular processes coupled with the importance of cell biology in various research fields and the rising prevalence of cancer worldwide. Are driving the growth of this market.
Which end user segment of the live cell imaging market is expected to dominate the market?
The pharmaceutical & biotechnology companies segment held the largest share by end user in 2022. Increasing R&D activities and the patent cliff of various blockbuster drugs are some factors driving the growth of this segment. As patents expire and generic alternatives become available, these companies face increased competition and the potential loss of market share. To maintain a competitive advantage, Pharma & biotech companies invest in live cell imaging technologies to gain a deeper understanding of cellular processes and develop novel drug candidates.
What is the market size for the live cell imaging market?
The global live cell imaging market is projected to reach USD 4.3 billion by 2028 from USD 2.7 billion in 2023, at a CAGR of 10.2% during the forecast period of 2023 to 2028.

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Live Cell Imaging Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
28
RESEARCH METHODOLOGY
33
EXECUTIVE SUMMARY
46
PREMIUM INSIGHTS
50
MARKET OVERVIEW
54
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Growing adoption of high-content screening techniques in drug discovery
    - Rising incidence of cancer
    - Growing availability of research funds
    RESTRAINTS
    - High cost of high-content screening systems
    OPPORTUNITIES
    - Increasing adoption of live cell imaging technologies in emerging economies
    - Applications of HCS in personalized medicine
    CHALLENGES
    - Maintaining cell viability and cellular environment in cell cultures
    - Image analysis and data management
  • 5.3 TECHNOLOGY ANALYSIS
  • 5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
  • 5.5 VALUE/SUPPLY CHAIN ANALYSIS
    VALUE CHAIN ANALYSIS
    SUPPLY CHAIN ANALYSIS
  • 5.6 REGULATORY ANALYSIS
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    - North America
    - Europe
    - Asia Pacific
    - Rest of the World
  • 5.7 PORTER’S FIVE FORCES ANALYSIS
    THREAT OF NEW ENTRANTS
    THREAT OF SUBSTITUTES
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    INTENSITY OF COMPETITIVE RIVALRY
  • 5.8 ECOSYSTEM ANALYSIS
  • 5.9 PRICING ANALYSIS
    AVERAGE SELLING PRICE, BY KEY PLAYER
    AVERAGE SELLING PRICE TREND
  • 5.10 KEY CONFERENCES & EVENTS IN 2022–2023
  • 5.11 KEY STAKEHOLDERS AND BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    BUYING CRITERIA FOR LIVE CELL IMAGING
  • 5.12 PATENT ANALYSIS
LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE
77
  • 6.1 INTRODUCTION
  • 6.2 INSTRUMENTS
    MICROSCOPES
    - Continuous technological advancements in microscopes to support market
    STANDALONE SYSTEMS
    - Seamless integration and workflow efficiency of standalone systems to boost demand
    CELL ANALYZERS
    - Accuracy and reproducibility of cell analyzers to support growth
    ACCESSORIES
    - Ability of accessories to optimize and enhance imaging conditions to boost demand
  • 6.3 CONSUMABLES
    REAGENTS
    - Widespread usage in life science research to fuel market growth
    ASSAY KITS
    - Repeat purchase of assay kits to drive market
    MEDIA
    - Increasing demand for optimized cell culture conditions to drive demand for media
    OTHER CONSUMABLES
  • 6.4 SOFTWARE
    TECHNOLOGICAL ADVANCEMENTS IN IMAGE ACQUISITION TO BOOST MARKET GROWTH
  • 6.5 SERVICES
    GROWING DEMAND FOR OUTSOURCED EXPERTISE AND SPECIALIZED SERVICES TO SUPPORT MARKET
LIVE CELL IMAGING MARKET, BY APPLICATION
114
  • 7.1 INTRODUCTION
  • 7.2 CELL BIOLOGY
  • 7.3 STEM CELLS
    GROWING FOCUS ON REGENERATIVE MEDICINE & ADVANCEMENTS IN STEM CELL RESEARCH TO BOOST MARKET
  • 7.4 DEVELOPMENTAL BIOLOGY
    GROWING INTEREST IN UNDERSTANDING ORGANOGENESIS AND TISSUE MORPHOGENESIS TO DRIVE DEMAND
  • 7.5 DRUG DISCOVERY
    GROWING USE OF HCS CELL-BASED ASSAYS IN DRUG DISCOVERY STUDIES TO DRIVE DEMAND
LIVE CELL IMAGING MARKET, BY TECHNOLOGY
126
  • 8.1 INTRODUCTION
  • 8.2 TIME-LAPSE MICROSCOPY
  • 8.3 FLUORESCENCE RESONANCE ENERGY TRANSFER (FRET)
    ADVANCEMENTS IN FLUORESCENT MATERIALS AND PROBES TO BOOST ADOPTION OF FRET TECHNOLOGY
  • 8.4 FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING (FRAP)
    INTEGRATION OF FRAP WITH LIVE CELL IMAGING MICROSCOPY TO CONTRIBUTE TO MARKET GROWTH
  • 8.5 HIGH-CONTENT SCREENING (HCS)
    GROWING ADOPTION OF HCS IN DRUG DISCOVERY AND TOXICITY SCREENING TO DRIVE GROWTH
  • 8.6 OTHER TECHNOLOGIES
LIVE CELL IMAGING MARKET, BY END USER
139
  • 9.1 INTRODUCTION
  • 9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    NEED TO ADHERE TO STRICT REGULATIONS TO DRIVE USE OF LIVE CELL IMAGING PRODUCTS AMONG PHARMA COMPANIES
  • 9.3 ACADEMIC & RESEARCH INSTITUTES
    INCREASING NUMBER OF DRUG DISCOVERY RESEARCH PROGRAMS TO DRIVE MARKET GROWTH
  • 9.4 CONTRACT RESEARCH ORGANIZATIONS
    GROWING OUTSOURCING OF R&D ACTIVITIES BY PHARMACEUTICAL COMPANIES TO DRIVE DEMAND
LIVE CELL IMAGING MARKET, BY REGION
148
  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    US
    - US to dominate live cell imaging market in North America
    CANADA
    - Government initiatives to promote research to support market growth
    NORTH AMERICA: RECESSION IMPACT
  • 10.3 EUROPE
    GERMANY
    - Presence of large number of academic research institutes to boost market
    UK
    - Investments by pharmaceutical sponsors for drug discovery services to support market
    FRANCE
    - Large pharmaceutical manufacturing industry to drive market growth
    ITALY
    - Strong research tradition, government funding, and collaborative research networks to fuel growth
    SPAIN
    - Rising R&D expenditure to boost market
    REST OF EUROPE
    EUROPE: RECESSION IMPACT
  • 10.4 ASIA PACIFIC
    CHINA
    - China to dominate APAC live cell imaging market
    JAPAN
    - Rising prominence of regenerative medicine research to drive market growth
    INDIA
    - Growing pharmaceutical industry to create favorable opportunities for market players
    REST OF ASIA PACIFIC (ROAPAC)
    ASIA PACIFIC: RECESSION IMPACT
  • 10.5 LATIN AMERICA
    BRAZIL
    - Gradual growth in research to contribute to growth
    REST OF LATIN AMERICA
    LATIN AMERICA: RECESSION IMPACT
  • 10.6 MIDDLE EAST & AFRICA
    GROWING PHARMACEUTICAL INDUSTRY TO DRIVE MARKET GROWTH
    MIDDLE EAST & AFRICA: RECESSION IMPACT
COMPETITIVE LANDSCAPE
213
  • 11.1 INTRODUCTION
  • 11.2 STRATEGIES ADOPTED BY KEY PLAYERS
  • 11.3 REVENUE SHARE ANALYSIS
  • 11.4 MARKET SHARE ANALYSIS
  • 11.5 COMPANY EVALUATION QUADRANT: KEY PLAYERS
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
  • 11.6 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS
    END-USER FOOTPRINT OF COMPANIES (25 COMPANIES)
    PRODUCT & SERVICE FOOTPRINT OF COMPANIES (25 COMPANIES)
    REGIONAL FOOTPRINT OF COMPANIES (25 COMPANIES)
  • 11.7 COMPANY EVALUATION QUADRANT: START-UPS/SMES
    PROGRESSIVE COMPANIES
    STARTING BLOCKS
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
  • 11.8 COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS
  • 11.9 COMPETITIVE SCENARIO AND TRENDS
    PRODUCT LAUNCHES
    DEALS
    OTHER DEVELOPMENTS
COMPANY PROFILES
229
  • 12.1 KEY COMPANIES
    DANAHER
    - Business overview
    - Products & services offered
    - Recent developments
    - MnM view
    ZEISS GROUP
    - Business overview
    - Products & services offered
    - Recent developments
    - MnM view
    SARTORIUS AG
    - Business overview
    - Products & services offered
    - Recent developments
    - MnM view
    THERMO FISHER SCIENTIFIC, INC.
    - Business overview
    - Products & services offered
    - MnM view
    OLYMPUS CORPORATION
    - Business overview
    - Products & services offered
    - MnM view
    PERKINELMER INC.
    - Business overview
    - Products & services offered
    - Recent developments
    NIKON CORPORATION
    - Business overview
    - Products & services offered
    - Recent developments
    ETALUMA, INC.
    - Business overview
    - Products & services offered
    - Recent developments
    CYTOSMART TECHNOLOGIES
    - Business overview
    - Products & services offered
    - Recent developments
    AGILENT TECHNOLOGIES, INC.
    - Business overview
    - Products & services offered
    - Recent developments
    NANOENTEK INC.
    - Business overview
    - Products & services offered
    BECTON, DICKINSON AND COMPANY
    - Business overview
    - Products & services offered
    GE HEALTHCARE
    - Business overview
    - Products & services offered
    BRUKER CORPORATION
    - Business overview
    - Products & services offered
    - Recent developments
    MERCK KGAA
    - Business overview
    - Products & services offered
    - Recent developments
    BIO-RAD LABORATORIES, INC.
    - Business overview
    - Products & services offered
    CORNING INCORPORATED
    - Business overview
    - Products & services offered
  • 12.2 OTHER PLAYERS
    BLUE-RAY BIOTECH CORP.
    CYTENA GMBH
    NANOLIVE SA
    ABBERIOR
    PHASE HOLOGRAPHIC IMAGING PHI AB
    CYTOSKELETON, INC.
    KEYENCE CORPORATION
    ALIGNED GENETICS, INC.
APPENDIX
284
  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (% GROWTH)
  • TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION)
  • TABLE 3 US HEALTH EXPENDITURE, 2023–2027 (USD MILLION)
  • TABLE 4 LIVE CELL IMAGING MARKET: IMPACT ANALYSIS
  • TABLE 5 ESTIMATED NEW CANCER CASES IN US, 2023
  • TABLE 6 INVESTMENT BREAKDOWN, 2021 (USD MILLION)
  • TABLE 7 LIVE CELL IMAGING MARKET: PORTER’S FIVE FORCES ANALYSIS
  • TABLE 8 SUPPLY CHAIN ECOSYSTEM
  • TABLE 9 AVERAGE SELLING PRICES
  • TABLE 10 LIVE CELL IMAGING: DETAILED LIST OF CONFERENCES & EVENTS
  • TABLE 11 LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 12 EXAMPLES OF INSTRUMENTS OFFERED BY MARKET PLAYERS
  • TABLE 13 LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 14 LIVE CELL IMAGING INSTRUMENTS MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 15 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 16 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 17 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 18 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 19 CONVENTIONAL MICROSCOPES OFFERED BY KEY MARKET PLAYERS
  • TABLE 20 CONFOCAL MICROSCOPES OFFERED BY KEY MARKET PLAYERS
  • TABLE 21 FLUORESCENCE MICROSCOPES OFFERED BY KEY MARKET PLAYERS
  • TABLE 22 LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 23 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 24 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 25 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 26 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 27 STANDALONE SYSTEMS OFFERED BY KEY MARKET PLAYERS
  • TABLE 28 LIVE CELL IMAGING INSTRUMENTS MARKET FOR STANDALONE SYSTEMS, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 29 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR STANDALONE SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 30 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET FOR STANDALONE SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 31 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET FOR STANDALONE SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 32 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR STANDALONE SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 33 CELL ANALYZERS OFFERED BY KEY MARKET PLAYERS
  • TABLE 34 LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 35 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 36 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 37 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 38 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 39 ACCESSORIES OFFERED BY KEY MARKET PLAYERS
  • TABLE 40 LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 41 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 42 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 43 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 44 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 45 LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 46 LIVE CELL IMAGING CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 47 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 48 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 49 ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 50 LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 51 REAGENTS OFFERED BY KEY MARKET PLAYERS
  • TABLE 52 LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 53 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 54 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 55 ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 56 LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 57 ASSAY KITS OFFERED BY KEY MARKET PLAYERS
  • TABLE 58 LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 59 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 60 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 61 ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 62 LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 63 MEDIA OFFERED BY KEY MARKET PLAYERS
  • TABLE 64 LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 65 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 66 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 67 ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 68 LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 69 OTHER CONSUMABLES OFFERED BY KEY MARKET PLAYERS
  • TABLE 70 OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 71 NORTH AMERICA: OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 72 EUROPE: OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 73 ASIA PACIFIC: OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 74 LATIN AMERICA: OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 75 SOFTWARE OFFERED BY KEY MARKET PLAYERS
  • TABLE 76 LIVE CELL IMAGING SOFTWARE MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 77 NORTH AMERICA: LIVE CELL IMAGING SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 78 EUROPE: LIVE CELL IMAGING SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 79 ASIA PACIFIC: LIVE CELL IMAGING SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 80 LATIN AMERICA: LIVE CELL IMAGING SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 81 LIVE CELL IMAGING SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 82 NORTH AMERICA: LIVE CELL IMAGING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 83 EUROPE: LIVE CELL IMAGING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 84 ASIA PACIFIC: LIVE CELL IMAGING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 85 LATIN AMERICA: LIVE CELL IMAGING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 86 LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 87 NUMBER OF NEW CANCER CASES, BY TYPE, 2020 VS. 2040
  • TABLE 88 LIVE CELL IMAGING MARKET FOR CELL BIOLOGY APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 89 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR CELL BIOLOGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 90 EUROPE: LIVE CELL IMAGING MARKET FOR CELL BIOLOGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 91 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR CELL BIOLOGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 92 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR CELL BIOLOGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 93 LIVE CELL IMAGING MARKET FOR STEM CELL APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 94 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR STEM CELL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 95 EUROPE: LIVE CELL IMAGING MARKET FOR STEM CELL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 96 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR STEM CELL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 97 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR STEM CELL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 98 LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 99 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 100 EUROPE: LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 101 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 102 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 103 LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 104 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 105 EUROPE: LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 106 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 107 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 108 LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 109 LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 110 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 111 EUROPE: LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 112 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 113 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 114 LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 115 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 116 EUROPE: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 117 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 118 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 119 LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 120 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 121 EUROPE: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 122 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 123 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 124 LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 125 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 126 EUROPE: LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 127 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 128 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 129 LIVE CELL IMAGING MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 130 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 131 EUROPE: LIVE CELL IMAGING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 132 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 133 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 134 LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
  • TABLE 135 LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 136 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 137 EUROPE: LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 138 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 139 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 140 LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 141 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 142 EUROPE: LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 143 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 144 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 145 LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 146 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 147 EUROPE: LIVE CELL IMAGING MARKET FOR F CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 148 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 149 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 150 LIVE CELL IMAGING MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 151 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 152 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 153 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 154 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 155 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 156 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 157 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
  • TABLE 158 US: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 159 US: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 160 US: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 161 US: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 162 US: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 163 US: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
  • TABLE 164 CANADA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 165 CANADA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 166 CANADA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 167 CANADA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 168 CANADA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 169 CANADA: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
  • TABLE 170 EUROPE: LIVE CELL IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 171 EUROPE: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 172 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 173 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 174 EUROPE: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 175 EUROPE: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 176 EUROPE: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
  • TABLE 177 GERMANY: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 178 GERMANY: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 179 GERMANY: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 180 GERMANY: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 181 GERMANY: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 182 GERMANY: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
  • TABLE 183 UK: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 184 UK: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 185 UK: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 186 UK: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 187 UK: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 188 UK: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
  • TABLE 189 FRANCE: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 190 FRANCE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 191 FRANCE: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 192 FRANCE: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 193 FRANCE: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 194 FRANCE: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
  • TABLE 195 ITALY: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 196 ITALY: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 197 ITALY: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 198 ITALY: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 199 ITALY: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 200 ITALY: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
  • TABLE 201 SPAIN: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 202 SPAIN: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 203 SPAIN: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 204 SPAIN: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 205 SPAIN: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 206 SPAIN: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
  • TABLE 207 REST OF EUROPE: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 208 REST OF EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 209 REST OF EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 210 REST OF EUROPE: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 211 REST OF EUROPE: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 212 REST OF EUROPE: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
  • TABLE 213 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 214 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 215 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 216 ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 217 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 218 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 219 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
  • TABLE 220 CHINA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 221 CHINA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 222 CHINA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 223 CHINA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 224 CHINA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 225 CHINA: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
  • TABLE 226 JAPAN: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 227 JAPAN: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 228 JAPAN: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 229 JAPAN: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 230 JAPAN: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 231 JAPAN: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
  • TABLE 232 INDIA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 233 INDIA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 234 INDIA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 235 INDIA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 236 INDIA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 237 INDIA: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
  • TABLE 238 REST OF ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 239 REST OF ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 240 REST OF ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 241 REST OF ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 242 REST OF ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 243 REST OF ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
  • TABLE 244 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 245 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 246 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 247 LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 248 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 249 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 250 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
  • TABLE 251 BRAZIL: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 252 BRAZIL: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 253 BRAZIL: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 254 BRAZIL: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 255 BRAZIL: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 256 BRAZIL: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
  • TABLE 257 REST OF LATIN AMERICA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 258 REST OF LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 259 REST OF LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 260 REST OF LATIN AMERICA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 261 REST OF LATIN AMERICA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 262 REST OF LATIN AMERICA: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
  • TABLE 263 MIDDLE EAST & AFRICA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 264 MIDDLE EAST & AFRICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 265 MIDDLE EAST & AFRICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 266 MIDDLE EAST & AFRICA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 267 MIDDLE EAST & AFRICA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 268 MIDDLE EAST & AFRICA: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
  • TABLE 269 LIVE CELL IMAGING MARKET: DEGREE OF COMPETITION
  • TABLE 270 END-USER FOOTPRINT ANALYSIS OF KEY PLAYERS IN LIVE CELL IMAGING MARKET
  • TABLE 271 PRODUCT & SERVICE FOOTPRINT ANALYSIS OF KEY PLAYERS IN LIVE CELL IMAGING MARKET
  • TABLE 272 REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS IN LIVE CELL IMAGING MARKET
  • TABLE 273 LIVE CELL IMAGING MARKET: DETAILED LIST OF KEY START-UP/SME PLAYERS
  • TABLE 274 LIVE CELL IMAGING MARKET: COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS
  • TABLE 275 LIVE CELL IMAGING MARKET: PRODUCT LAUNCHES, JANUARY 2020–DECEMBER 2022
  • TABLE 276 LIVE CELL IMAGING MARKET: DEALS, JANUARY 2020–DECEMBER 2022
  • TABLE 277 LIVE CELL IMAGING MARKET: OTHER DEVELOPMENTS, JANUARY 2020–DECEMBER 2022
  • TABLE 278 DANAHER: BUSINESS OVERVIEW
  • TABLE 279 ZEISS GROUP: BUSINESS OVERVIEW
  • TABLE 280 SARTORIUS AG: BUSINESS OVERVIEW
  • TABLE 281 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW
  • TABLE 282 OLYMPUS CORPORATION: BUSINESS OVERVIEW
  • TABLE 283 PERKINELMER INC.: BUSINESS OVERVIEW
  • TABLE 284 NIKON CORPORATION: BUSINESS OVERVIEW
  • TABLE 285 ETALUMA, INC.: BUSINESS OVERVIEW
  • TABLE 286 CYTOSMART TECHNOLOGIES.: BUSINESS OVERVIEW
  • TABLE 287 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW
  • TABLE 288 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
  • TABLE 289 GE HEALTHCARE: BUSINESS OVERVIEW
  • TABLE 290 BRUKER CORPORATION: BUSINESS OVERVIEW
  • TABLE 291 MERCK KGAA: BUSINESS OVERVIEW
  • TABLE 292 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
  • TABLE 293 CORNING INCORPORATED: BUSINESS OVERVIEW
LIST OF FIGURES
 
  • FIGURE 1 LIVE CELL IMAGING MARKET SEGMENTATION
  • FIGURE 2 RESEARCH DESIGN
  • FIGURE 3 LIVE CELL IMAGING MARKET: BREAKDOWN OF PRIMARIES
  • FIGURE 4 MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS, 2022
  • FIGURE 5 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2022
  • FIGURE 6 ILLUSTRATIVE EXAMPLE OF DANAHER CORPORATION: REVENUE SHARE ANALYSIS, 2022
  • FIGURE 7 MARKET VALIDATION FROM PRIMARY EXPERTS
  • FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 9 LIVE CELL IMAGING MARKET: CAGR PROJECTIONS, 2022–2028
  • FIGURE 10 LIVE CELL IMAGING MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 11 DATA TRIANGULATION METHODOLOGY
  • FIGURE 12 LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION)
  • FIGURE 13 LIVE CELL IMAGING MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
  • FIGURE 14 LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION)
  • FIGURE 15 LIVE CELL IMAGING MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
  • FIGURE 16 GEOGRAPHICAL SNAPSHOT OF LIVE CELL IMAGING MARKET
  • FIGURE 17 GROWING ADOPTION OF HIGH-CONTENT SCREENING TECHNIQUES IN DRUG DISCOVERY TO DRIVE MARKET GROWTH
  • FIGURE 18 INSTRUMENTS DOMINATED NORTH AMERICAN LIVE CELL IMAGING MARKET IN 2022
  • FIGURE 19 INSTRUMENTS TO CONTINUE TO DOMINATE MARKET BY 2028
  • FIGURE 20 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
  • FIGURE 21 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE IN LIVE CELL IMAGING MARKET FROM 2023 TO 2028
  • FIGURE 22 LIVE CELL IMAGING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 23 GLOBAL CANCER INCIDENCE & MORTALITY, 2020
  • FIGURE 24 REVENUE SHIFT & NEW POCKETS FOR LIVE CELL IMAGING PRODUCT & SERVICE PROVIDERS
  • FIGURE 25 LIVE CELL IMAGING MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 26 LIVE CELL IMAGING MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF LIVE CELL IMAGING PRODUCTS
  • FIGURE 28 KEY BUYING CRITERIA FOR END USERS
  • FIGURE 29 LIVE CELL IMAGING MARKET: PATENT APPLICATIONS (JANUARY 2020–APRIL 2023)
  • FIGURE 30 NORTH AMERICA: LIVE CELL IMAGING MARKET SNAPSHOT
  • FIGURE 31 UK: PHARMACEUTICAL R&D EXPENDITURE, 2011–2020 (USD MILLION)
  • FIGURE 32 LIVE CELL IMAGING MARKET: STRATEGIES ADOPTED BY KEY PLAYERS
  • FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS, 2020–2022
  • FIGURE 34 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2022
  • FIGURE 35 LIVE CELL IMAGING MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022
  • FIGURE 36 LIVE CELL IMAGING MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022
  • FIGURE 37 DANAHER: COMPANY SNAPSHOT (2022)
  • FIGURE 38 ZEISS GROUP: COMPANY SNAPSHOT (2022)
  • FIGURE 39 SARTORIUS AG: COMPANY SNAPSHOT (2022)
  • FIGURE 40 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2022)
  • FIGURE 41 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2022)
  • FIGURE 42 PERKINELMER INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 43 NIKON CORPORATION: COMPANY SNAPSHOT (2022)
  • FIGURE 44 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2022)
  • FIGURE 45 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022)
  • FIGURE 46 GE HEALTHCARE: COMPANY SNAPSHOT (2022)
  • FIGURE 47 BRUKER CORPORATION: COMPANY SNAPSHOT (2022)
  • FIGURE 48 MERCK KGAA: COMPANY SNAPSHOT (2022)
  • FIGURE 49 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022)
  • FIGURE 50 CORNING INCORPORATED: COMPANY SNAPSHOT (2022)

This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global live cell imaging market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

Secondary Research

The secondary sources referred to for this research study include publications from government sources, such as American Society for Cell Biology (ASCB), Cancer Research UK (CRUK), International Society for Stem Cell Research (ISSCR), European Molecular Biology Organization (EMBO), Clinical and Contract Research Association (CCRA), Association of International Contract Research Organizations (AICROS), Clinical and Contract Research Association (CCRA), American Association of Pharmaceutical Scientists (AAPS), Eurostat, Food and Drug Administration (FDA), Pharmaceutical Research and Manufacturers of America (PhRMA), PubMed, Government Associations. Secondary sources also include corporate and regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines & research journals; press releases; and trade, business, and professional associations. Secondary data was collected and analyzed to arrive at the overall size of the global live cell imaging market, which was validated through primary research.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global live cell imaging market scenario through secondary research. Several primary interviews were conducted with market experts from the demand side, such as personnel from pharmaceutical and biopharmaceutical industries, CMOs and CROs, academic & research institutes, and experts from the supply side, such as C-level and D-level executives, product managers, marketing & sales managers of key manufacturers, distributors, and channel partners. These interviews were conducted across four major regions, including the Asia Pacific, North America, Europe, Latin America, and the Middle East & Africa. Approximately 80% and 20% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

The following is a breakdown of the primary respondents:

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The global size of the market was estimated through multiple approaches. A detailed market estimation approach was followed to estimate and validate the value of the live cell imaging market and other dependent submarkets. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and market have been identified through extensive primary and secondary research.
  • The revenues generated from the live cell imaging business of leading players have been determined through primary and secondary research.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Data Triangulation

After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Market Definition

Live cell imaging involves the detailed study of living cells using images acquired from microscopes and high-content screening systems. This technique is mainly used in scientific research activities for a better understanding of biological functions through the study of cellular dynamics.

Stakeholders

  • Manufacturers of live cell imaging equipment and consumables
  • Suppliers and distributors of live cell imaging technologies
  • Research institutes and academic centers
  • Pharmaceutical & biotechnology companies
  • Contract research organizations (CROs)
  • Business research and consulting service providers
  • Venture capitalists
  • Regulatory bodies
  • Government bodies/municipal corporations

Report Objectives

  • To define, describe, and forecast the global live cell imaging market based on product & service, application, technology, end user, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
  • To profile the key players and comprehensively analyze their product & service portfolios, market positions, and core competencies
  • To track and analyze competitive developments such as acquisitions, product/ service launches, expansions, agreements, partnerships, and collaborations in the market

Previous Versions of this Report

Live Cell Imaging Market by Product (Instruments, Consumables, Software, Services) Application (Cell Biology, Drug Discovery) Technology (Time-lapse Microscopy, FRET) End User (Contract Research Organization, Research Institutes) - Global Forecast to 2025

Report Code BT 3390
Published in Oct, 2020, By MarketsandMarkets™

Live Cell Imaging Market by Product (Instruments, Consumables, Software, Services), Application (Cell Biology, Stem Cells, Drug Discovery), End User (Pharmaceutical & Biotechnology Companies, Research Institutes) - Global Forecasts to 2023

Report Code BT 3390
Published in Feb, 2019, By MarketsandMarkets™

Live Cell Imaging Market by Product (Instruments, Consumables, Software, Services), Application (Cell Biology, Stem Cells, Drug Discovery), End User (Pharmaceutical & Biotechnology Companies, Research Institutes) - Global Forecasts to 2023

Report Code BT 3390
Published in Apr, 2015, By MarketsandMarkets™

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Live Cell Imaging Market

DMCA.com Protection Status